[ET Net News Agency, 13 November 2024] REMEGEN (09995) fell 10.1% to HK$17.12, dipping
below the 10-D SMA of HK$18.66.
It hits an intra-day low of HK$17.12, and an intra-day high of HK$18.94. The total
shares traded was 2.1 million, with a value of HK$37.18m. The active buy/sell ratio is
44:56, with net selling turnover of HK$4.43m. CHINA INV INFO accounts for greatest net
responsive buying turnover of HK$5.93m, with volume weighted average price of HK$17.632.
J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$1.79m,
with volume weighted average price of HK$17.752. The stock has fallen a combined 10.6%
over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 17.120 % Chg -10.08%
High 18.940 Low 17.120
Shares Tr 2.1m Turnover 37.18m
10-D SMA 18.660 %H.V 77.688
20-D SMA 16.760 VWAP 17.736
50-D SMA 15.123 RSI14 51.283
----------------------------------
Status: Dipping below the 10-D SMA, active buy/sell ratio is 44:56, with net selling
turnover of HK$4.43m, falling a combined 10.6% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 17.12 -10.08
IMMUNEONCO-B (01541) 8.62 -7.41
GENSCRIPT BIO (01548) 10.68 -2.20
INNOVENT BIO (01801) 36.90 -2.25
EVEREST MED-B (01952) 34.80 -4.00
CARSGEN-B (02171) 7.36 -10.90
WUXI BIO (02269) 15.82 -4.93
BEIGENE (06160) 118.00 -3.12
ASCENTAGE-B (06855) 41.70 -5.66
AKESO (09926) 67.05 -4.76
---------------------------------------------
(ed)